Loading...
Chemoprevention in Patients with Peutz‐Jeghers Syndrome: Lessons Learned
LESSONS LEARNED. Motivating patients to enroll in chemopreventive studies is challenging. Chemoprevention with toxic drugs is not feasible. BACKGROUND. LKB1 mutations are the underlying genetic abnormality causing Peutz‐Jeghers syndrome (PJS) and are a potential target for everolimus. In this phase...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5896716/ https://ncbi.nlm.nih.gov/pubmed/29371475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0682 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|